常染色体显性多囊肾病肾切除术:ERA基因与肾脏工作组共识声明
专家组认为肾切除术可用于多种指征,属中等风险手术,移植前、同期或移植后施行对移植肾功能影响小,急诊手术并发症率增高,决策应多学科共享。
要点
- 肾切除术可用于多种指征,属中等风险手术,死亡风险可接受。
- 移植前、同期或移植后行肾切除术对移植肾功能影响小。
- 急诊肾切除术并发症率似乎增高,应避免非计划急诊手术。
核心结论
- 肾切除术可用于多种指征,属中等风险手术,死亡风险可接受,移植前、同期或移植后施行对移植肾功能影响小。
- 急诊肾切除术并发症率似乎增高,决策应基于共享决策并优先多学科会诊。
研究设计与样本
- 辅以面向泌尿外科医生、肾内科医生和移植外科医生的探索性问卷。
- 由ERA基因与肾脏工作组及EAU移植泌尿外科分会专家经三轮德尔菲调查达成共识。
主要发现
- 共形成23条实践要点/声明,全部达成共识。
- 肾切除术可用于多种指征,属中等风险手术,死亡风险可接受。
- 移植前、同期或移植后行肾切除术对移植肾功能影响小。
- 急诊手术时并发症率似乎增高。
- 肾动脉栓塞作为潜在替代方案的数据被探索并总结。
关键数值与推荐
- 移植评估期应常规用问卷评估患者症状负担。
- 肾切除术决策及替代方案(如肾栓塞)应共享决策,最好经多学科会诊。
- 共23条实践要点/声明全部达成共识。
临床怎么用
- 移植评估时常规问卷评估症状负担,辅助肾切除术指征判断。
- 优先择期在移植前、同期或移植后行肾切除术,避免急诊手术。
- 决策前多学科会诊并讨论肾动脉栓塞等替代方案。
局限性
- 证据基于系统综述及专家共识,部分问题仅能定性汇总。
- 探索性问卷和德尔菲调查存在专家意见偏倚可能。
- 肾动脉栓塞替代肾切除术的数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A substantial number of patients with autosomal dominant polycystic kidney disease (ADPKD) undergo a nephrectomy, especially in workup for a kidney transplantation. Currently, there is no evidence-based algorithm to guide clinicians about which patients should undergo nephrectomy, the optimal timing of this procedure, or the preferred surgical technique. This systematic review-based consensus statement aimed to answer important questions regarding nephrectomy in ADPKD. A literature review was performed and extended to a meta-analysis when possible. For this purpose, PubMed and EMBASE were searched up to May 2024. Fifty-four publications, describing a total of 2391 procedures, were included. In addition, an exploratory questionnaire was sent to urologists, nephrologists, and transplant surgeons. These sources were used to develop practice points about indications, complications, mortality, and timing and technique of nephrectomy. In addition, data on renal embolization as a potential alternative to nephrectomy were explored and summarized. To reach consensus, practice points were defined and improved in three Delphi survey rounds by experts of the European Renal Association Working Group Genes & Kidney and the European Association of Urology Section of Transplantation Urology. A total of 23 practice points/statements were developed, all of which reached consensus. Among others, it was deemed that nephrectomy can be performed successfully for various indications and is an intermediate risk procedure with acceptable mortality and minimal impact on kidney graft function when performed before, in the same session or after transplantation. The complication rate seems to increase when the procedure is performed as an emergency. During the workup for transplantation, patient complaints should be assessed routinely by questionnaires to indicate symptom burden. Deciding on the need for nephrectomy and exploring potential alternatives such as kidney embolization should be a process of shared decision-making, preferably after multidisciplinary consultation.
引用
- Geertsema P, Gansevoort RT, Arici M, et al. Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working Group. Nephrol Dial Transplant. 2025. PMID: 39848914. doi:10.1093/ndt/gfaf019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。